glp 1 agonists and depression Insights into a possible role of glucagon-like peptide-1 receptor in the treatment of | Pharmacological Reports Glucagon-like peptide-1 receptor agonists and
Description
One consideration unique to covering GLP-1s for anti-obesity is that while plan sponsors will incur new short-term pharmacy costs, expected cost offsets such as lower medical benefit costs may not materialize until years later
doi: 10.1080/14656566.2019.1571040 [DOI] [PubMed] [Google Scholar] 122
One of the most exciting medical breakthroughs in the field of weight loss is the use of GLP-1 receptor agonists a class of medications that mimic a naturally occurring hormone in the body to support effective, long-term weight loss
E.VendruscoloL
doi:10.1016/j.brainres.2015.12.052 215
iScience 26 , 106848 (2023)
